Kyorin: Sales Down 3.3% due to Decline in Sales of Gatiflo

November 17, 2003
Kyorin Pharmaceutical announced a 3.3% decline in sales compared to the corresponding period of the previous year in its consolidated semiannual settlement of accounts for the year ending March 2004. Contributing to the decline was a drop in domestic sales...read more